nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—adrenal medulla—Parkinson's disease	0.076	0.222	CbGeAlD
Sulindac—AKR1B1—peripheral nervous system—Parkinson's disease	0.0338	0.0989	CbGeAlD
Sulindac—AKR1B1—embryo—Parkinson's disease	0.0124	0.0361	CbGeAlD
Sulindac—AKR1B1—forebrain—Parkinson's disease	0.0109	0.0319	CbGeAlD
Sulindac—PTGDR2—cerebellum—Parkinson's disease	0.0105	0.0307	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—Parkinson's disease	0.00924	0.027	CbGeAlD
Sulindac—MAPK3—embryo—Parkinson's disease	0.00896	0.0262	CbGeAlD
Sulindac—PPARD—forebrain—Parkinson's disease	0.00859	0.0251	CbGeAlD
Sulindac—PTGDR2—brain—Parkinson's disease	0.00853	0.0249	CbGeAlD
Sulindac—MAPK3—forebrain—Parkinson's disease	0.00792	0.0231	CbGeAlD
Sulindac—AKR1B1—medulla oblongata—Parkinson's disease	0.0079	0.0231	CbGeAlD
Sulindac—AKR1B1—midbrain—Parkinson's disease	0.00722	0.0211	CbGeAlD
Sulindac—AKR1B1—spinal cord—Parkinson's disease	0.00704	0.0206	CbGeAlD
Sulindac—MAPK3—cardiovascular system—Parkinson's disease	0.0067	0.0196	CbGeAlD
Sulindac—AKR1B1—head—Parkinson's disease	0.00626	0.0183	CbGeAlD
Sulindac—AKR1B1—nervous system—Parkinson's disease	0.00593	0.0173	CbGeAlD
Sulindac—MAPK3—medulla oblongata—Parkinson's disease	0.00572	0.0167	CbGeAlD
Sulindac—AKR1B1—central nervous system—Parkinson's disease	0.00571	0.0167	CbGeAlD
Sulindac—PPARD—midbrain—Parkinson's disease	0.00568	0.0166	CbGeAlD
Sulindac—AKR1B1—cerebellum—Parkinson's disease	0.00558	0.0163	CbGeAlD
Sulindac—MAPK3—midbrain—Parkinson's disease	0.00523	0.0153	CbGeAlD
Sulindac—MAPK3—spinal cord—Parkinson's disease	0.0051	0.0149	CbGeAlD
Sulindac—PPARD—head—Parkinson's disease	0.00492	0.0144	CbGeAlD
Sulindac—PPARD—nervous system—Parkinson's disease	0.00467	0.0136	CbGeAlD
Sulindac—MAPK3—head—Parkinson's disease	0.00454	0.0133	CbGeAlD
Sulindac—AKR1B1—brain—Parkinson's disease	0.00454	0.0132	CbGeAlD
Sulindac—PPARD—central nervous system—Parkinson's disease	0.00449	0.0131	CbGeAlD
Sulindac—PPARD—cerebellum—Parkinson's disease	0.00439	0.0128	CbGeAlD
Sulindac—MAPK3—nervous system—Parkinson's disease	0.0043	0.0126	CbGeAlD
Sulindac—MAPK3—central nervous system—Parkinson's disease	0.00414	0.0121	CbGeAlD
Sulindac—MAPK3—cerebellum—Parkinson's disease	0.00405	0.0118	CbGeAlD
Sulindac—PPARD—brain—Parkinson's disease	0.00357	0.0104	CbGeAlD
Sulindac—MAPK3—brain—Parkinson's disease	0.00329	0.0096	CbGeAlD
Sulindac—SLC22A6—brain—Parkinson's disease	0.00251	0.00735	CbGeAlD
Sulindac—PTGS2—embryo—Parkinson's disease	0.00233	0.0068	CbGeAlD
Sulindac—PTGS1—forebrain—Parkinson's disease	0.00215	0.00629	CbGeAlD
Sulindac—PTGS2—forebrain—Parkinson's disease	0.00206	0.00601	CbGeAlD
Sulindac—PTGS1—cardiovascular system—Parkinson's disease	0.00182	0.00532	CbGeAlD
Sulindac—PTGS2—cardiovascular system—Parkinson's disease	0.00174	0.00508	CbGeAlD
Sulindac—ALB—brain—Parkinson's disease	0.00157	0.00458	CbGeAlD
Sulindac—PTGS2—medulla oblongata—Parkinson's disease	0.00149	0.00434	CbGeAlD
Sulindac—CYP1A1—head—Parkinson's disease	0.0014	0.0041	CbGeAlD
Sulindac—PTGS1—spinal cord—Parkinson's disease	0.00139	0.00405	CbGeAlD
Sulindac—PTGS2—midbrain—Parkinson's disease	0.00136	0.00397	CbGeAlD
Sulindac—CYP1A1—nervous system—Parkinson's disease	0.00133	0.00389	CbGeAlD
Sulindac—PTGS2—spinal cord—Parkinson's disease	0.00133	0.00387	CbGeAlD
Sulindac—CYP1A1—central nervous system—Parkinson's disease	0.00128	0.00374	CbGeAlD
Sulindac—PTGS1—head—Parkinson's disease	0.00123	0.0036	CbGeAlD
Sulindac—PTGS2—head—Parkinson's disease	0.00118	0.00344	CbGeAlD
Sulindac—PTGS1—nervous system—Parkinson's disease	0.00117	0.00341	CbGeAlD
Sulindac—PTGS1—central nervous system—Parkinson's disease	0.00113	0.00329	CbGeAlD
Sulindac—PTGS2—nervous system—Parkinson's disease	0.00112	0.00326	CbGeAlD
Sulindac—PTGS2—central nervous system—Parkinson's disease	0.00108	0.00314	CbGeAlD
Sulindac—PTGS2—cerebellum—Parkinson's disease	0.00105	0.00307	CbGeAlD
Sulindac—CYP1A1—brain—Parkinson's disease	0.00102	0.00297	CbGeAlD
Sulindac—PTGS1—brain—Parkinson's disease	0.000893	0.00261	CbGeAlD
Sulindac—PTGS2—brain—Parkinson's disease	0.000854	0.00249	CbGeAlD
Sulindac—MAPK3—Signaling by GPCR—DRD3—Parkinson's disease	0.000129	0.000196	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000128	0.000195	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GSTM1—Parkinson's disease	0.000127	0.000194	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	0.000127	0.000193	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000126	0.000192	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—Parkinson's disease	0.000123	0.000187	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000123	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—Parkinson's disease	0.000123	0.000186	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GPX1—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Sulindac—ALB—Metabolism—TALDO1—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Sulindac—ALB—Metabolism—OMD—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—MAPK8—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DBH—Parkinson's disease	0.000121	0.000185	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GBA—Parkinson's disease	0.000121	0.000185	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—FBP1—Parkinson's disease	0.000121	0.000185	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—Parkinson's disease	0.000121	0.000184	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCH1—Parkinson's disease	0.000121	0.000184	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000121	0.000184	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000121	0.000183	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00012	0.000183	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000119	0.000181	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—HSPA8—Parkinson's disease	0.000119	0.000181	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000119	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CTGF—Parkinson's disease	0.000118	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PDYN—Parkinson's disease	0.000118	0.00018	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.000116	0.000177	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR7—Parkinson's disease	0.000116	0.000177	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—DRD2—Parkinson's disease	0.000116	0.000177	CbGpPWpGaD
Sulindac—PTGS2—Disease—SNCA—Parkinson's disease	0.000116	0.000176	CbGpPWpGaD
Sulindac—PTGS2—Disease—RPL6—Parkinson's disease	0.000116	0.000176	CbGpPWpGaD
Sulindac—ALB—Hemostasis—FGB—Parkinson's disease	0.000116	0.000176	CbGpPWpGaD
Sulindac—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000116	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—INS—Parkinson's disease	0.000115	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000114	0.000174	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—Parkinson's disease	0.000114	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000114	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—Parkinson's disease	0.000113	0.000172	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTHFR—Parkinson's disease	0.000113	0.000171	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—DDC—Parkinson's disease	0.000112	0.000171	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000112	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—Parkinson's disease	0.000112	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GFAP—Parkinson's disease	0.000111	0.000169	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCH1—Parkinson's disease	0.00011	0.000168	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GRM5—Parkinson's disease	0.00011	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ADRBK1—Parkinson's disease	0.00011	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—Parkinson's disease	0.00011	0.000167	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000109	0.000166	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000109	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—HSPA1A—Parkinson's disease	0.000108	0.000165	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—FBP1—Parkinson's disease	0.000108	0.000164	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DBH—Parkinson's disease	0.000108	0.000164	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GBA—Parkinson's disease	0.000108	0.000164	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000106	0.000161	CbGpPWpGaD
Sulindac—PPARD—Metabolism—APOE—Parkinson's disease	0.000105	0.000159	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000105	0.000159	CbGpPWpGaD
Sulindac—MAPK3—Disease—ADRBK1—Parkinson's disease	0.000101	0.000154	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000101	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Disease—HSPA1A—Parkinson's disease	0.000101	0.000153	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.0001	0.000152	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	9.95e-05	0.000151	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CASP3—Parkinson's disease	9.91e-05	0.000151	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—Parkinson's disease	9.85e-05	0.00015	CbGpPWpGaD
Sulindac—ALB—Metabolism—GBA—Parkinson's disease	9.83e-05	0.000149	CbGpPWpGaD
Sulindac—ALB—Metabolism—FBP1—Parkinson's disease	9.83e-05	0.000149	CbGpPWpGaD
Sulindac—ALB—Metabolism—DBH—Parkinson's disease	9.83e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	9.77e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF20—Parkinson's disease	9.65e-05	0.000147	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.63e-05	0.000146	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	9.6e-05	0.000146	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PLA2G6—Parkinson's disease	9.55e-05	0.000145	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MAOB—Parkinson's disease	9.45e-05	0.000144	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	9.39e-05	0.000143	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADORA2A—Parkinson's disease	9.36e-05	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDN1—Parkinson's disease	9.31e-05	0.000142	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MAPK8—Parkinson's disease	9.11e-05	0.000139	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ND3—Parkinson's disease	9.07e-05	0.000138	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MCCC1—Parkinson's disease	9.07e-05	0.000138	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9e-05	0.000137	CbGpPWpGaD
Sulindac—PPARD—Metabolism—INS—Parkinson's disease	8.95e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ABL1—Parkinson's disease	8.94e-05	0.000136	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DDC—Parkinson's disease	8.92e-05	0.000136	CbGpPWpGaD
Sulindac—PTGS2—Disease—RPL14—Parkinson's disease	8.79e-05	0.000134	CbGpPWpGaD
Sulindac—PTGS2—Disease—RPL23A—Parkinson's disease	8.79e-05	0.000134	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INSR—Parkinson's disease	8.64e-05	0.000131	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SOD1—Parkinson's disease	8.6e-05	0.000131	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.59e-05	0.000131	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—OMD—Parkinson's disease	8.53e-05	0.00013	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TALDO1—Parkinson's disease	8.53e-05	0.00013	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTA4—Parkinson's disease	8.42e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HGF—Parkinson's disease	8.41e-05	0.000128	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.31e-05	0.000126	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—Parkinson's disease	8.29e-05	0.000126	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.25e-05	0.000125	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ABL1—Parkinson's disease	8.21e-05	0.000125	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF20—Parkinson's disease	8.2e-05	0.000125	CbGpPWpGaD
Sulindac—PTGS2—Disease—RPS8—Parkinson's disease	8.2e-05	0.000125	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF2—Parkinson's disease	8.17e-05	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGB—Parkinson's disease	8.16e-05	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR2A—Parkinson's disease	8.15e-05	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR1A—Parkinson's disease	8.12e-05	0.000123	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	8.09e-05	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAC1—Parkinson's disease	8e-05	0.000122	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DDC—Parkinson's disease	7.91e-05	0.00012	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	7.91e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—Parkinson's disease	7.91e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DRD1—Parkinson's disease	7.84e-05	0.000119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—Parkinson's disease	7.77e-05	0.000118	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HGF—Parkinson's disease	7.72e-05	0.000117	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCH1—Parkinson's disease	7.71e-05	0.000117	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DRD3—Parkinson's disease	7.6e-05	0.000115	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PLA2G6—Parkinson's disease	7.58e-05	0.000115	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MAOB—Parkinson's disease	7.51e-05	0.000114	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTA4—Parkinson's disease	7.47e-05	0.000114	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.38e-05	0.000112	CbGpPWpGaD
Sulindac—ALB—Metabolism—DDC—Parkinson's disease	7.21e-05	0.00011	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.17e-05	0.000109	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.14e-05	0.000109	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRBK1—Parkinson's disease	7.09e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—Parkinson's disease	7.04e-05	0.000107	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP2D6—Parkinson's disease	7.03e-05	0.000107	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.96e-05	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAPK8—Parkinson's disease	6.94e-05	0.000106	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CTGF—Parkinson's disease	6.9e-05	0.000105	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GBA—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—FBP1—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DBH—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR7—Parkinson's disease	6.87e-05	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DRD2—Parkinson's disease	6.87e-05	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—Parkinson's disease	6.86e-05	0.000104	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTA4—Parkinson's disease	6.81e-05	0.000104	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	6.73e-05	0.000102	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.73e-05	0.000102	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MAOB—Parkinson's disease	6.66e-05	0.000101	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP2E1—Parkinson's disease	6.43e-05	9.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—APOE—Parkinson's disease	6.39e-05	9.71e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NQO1—Parkinson's disease	6.35e-05	9.66e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.34e-05	9.64e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TH—Parkinson's disease	6.26e-05	9.52e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—Parkinson's disease	6.22e-05	9.46e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLA2G6—Parkinson's disease	6.13e-05	9.33e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MAOB—Parkinson's disease	6.07e-05	9.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ADRBK1—Parkinson's disease	6.02e-05	9.16e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYCS—Parkinson's disease	6.01e-05	9.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HSPA1A—Parkinson's disease	5.98e-05	9.09e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—Parkinson's disease	5.82e-05	8.85e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.78e-05	8.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF2—Parkinson's disease	5.76e-05	8.75e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP2D6—Parkinson's disease	5.58e-05	8.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1R—Parkinson's disease	5.57e-05	8.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDN1—Parkinson's disease	5.5e-05	8.36e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CTGF—Parkinson's disease	5.48e-05	8.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—INS—Parkinson's disease	5.46e-05	8.3e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—COMT—Parkinson's disease	5.33e-05	8.1e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTP1—Parkinson's disease	5.3e-05	8.06e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MAOA—Parkinson's disease	5.29e-05	8.04e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HMOX1—Parkinson's disease	5.23e-05	7.95e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP2E1—Parkinson's disease	5.1e-05	7.76e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGF—Parkinson's disease	5.05e-05	7.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DDC—Parkinson's disease	5.05e-05	7.67e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NQO1—Parkinson's disease	5.04e-05	7.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—Parkinson's disease	5.02e-05	7.63e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ABCB1—Parkinson's disease	5.02e-05	7.63e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TH—Parkinson's disease	4.97e-05	7.56e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	4.95e-05	7.53e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTM1—Parkinson's disease	4.87e-05	7.41e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CTGF—Parkinson's disease	4.86e-05	7.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2A—Parkinson's disease	4.81e-05	7.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYCS—Parkinson's disease	4.77e-05	7.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTA4—Parkinson's disease	4.77e-05	7.25e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.71e-05	7.15e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GPX1—Parkinson's disease	4.66e-05	7.09e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	4.53e-05	6.88e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2D6—Parkinson's disease	4.51e-05	6.86e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NQO1—Parkinson's disease	4.48e-05	6.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—Parkinson's disease	4.47e-05	6.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—Parkinson's disease	4.43e-05	6.74e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTGF—Parkinson's disease	4.43e-05	6.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TH—Parkinson's disease	4.41e-05	6.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—Parkinson's disease	4.41e-05	6.71e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—Parkinson's disease	4.3e-05	6.54e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	4.29e-05	6.52e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MAOB—Parkinson's disease	4.25e-05	6.46e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYCS—Parkinson's disease	4.24e-05	6.44e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—COMT—Parkinson's disease	4.23e-05	6.43e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTP1—Parkinson's disease	4.21e-05	6.4e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MAOA—Parkinson's disease	4.2e-05	6.38e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—Parkinson's disease	4.15e-05	6.31e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2E1—Parkinson's disease	4.13e-05	6.28e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NQO1—Parkinson's disease	4.08e-05	6.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—Parkinson's disease	4.08e-05	6.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—Parkinson's disease	4.04e-05	6.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.04e-05	6.15e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—TH—Parkinson's disease	4.02e-05	6.12e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—Parkinson's disease	4.01e-05	6.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCB1—Parkinson's disease	3.98e-05	6.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—Parkinson's disease	3.87e-05	5.88e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYCS—Parkinson's disease	3.86e-05	5.87e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—Parkinson's disease	3.82e-05	5.81e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—Parkinson's disease	3.8e-05	5.78e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—COMT—Parkinson's disease	3.75e-05	5.7e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTP1—Parkinson's disease	3.73e-05	5.68e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MAOA—Parkinson's disease	3.73e-05	5.66e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX1—Parkinson's disease	3.7e-05	5.63e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—Parkinson's disease	3.68e-05	5.6e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCB1—Parkinson's disease	3.53e-05	5.37e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—Parkinson's disease	3.43e-05	5.22e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—Parkinson's disease	3.42e-05	5.21e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—COMT—Parkinson's disease	3.42e-05	5.2e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—Parkinson's disease	3.42e-05	5.2e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTP1—Parkinson's disease	3.4e-05	5.18e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MAOA—Parkinson's disease	3.4e-05	5.16e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—Parkinson's disease	3.36e-05	5.1e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX1—Parkinson's disease	3.29e-05	5e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—Parkinson's disease	3.25e-05	4.93e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCB1—Parkinson's disease	3.22e-05	4.9e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—Parkinson's disease	3.18e-05	4.84e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.16e-05	4.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—Parkinson's disease	3.13e-05	4.76e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.1e-05	4.71e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—Parkinson's disease	3.03e-05	4.61e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX1—Parkinson's disease	3e-05	4.55e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.89e-05	4.39e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.85e-05	4.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—Parkinson's disease	2.85e-05	4.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—Parkinson's disease	2.83e-05	4.3e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—Parkinson's disease	2.82e-05	4.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TH—Parkinson's disease	2.81e-05	4.28e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—Parkinson's disease	2.76e-05	4.2e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—Parkinson's disease	2.72e-05	4.13e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.7e-05	4.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—Parkinson's disease	2.61e-05	3.98e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—Parkinson's disease	2.58e-05	3.93e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—Parkinson's disease	2.57e-05	3.91e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—Parkinson's disease	2.41e-05	3.67e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—COMT—Parkinson's disease	2.39e-05	3.64e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—Parkinson's disease	2.38e-05	3.63e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.38e-05	3.62e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.38e-05	3.61e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.35e-05	3.57e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.25e-05	3.43e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—Parkinson's disease	2.2e-05	3.34e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.19e-05	3.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.1e-05	3.19e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.93e-05	2.94e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—Parkinson's disease	1.8e-05	2.74e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—Parkinson's disease	1.67e-05	2.54e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—Parkinson's disease	1.54e-05	2.34e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—Parkinson's disease	1.42e-05	2.16e-05	CbGpPWpGaD
